GATA3 Expression in Human Tumors: A Tissue Microarray Study on 16,557 Tumors.

Area of Science:

• Oncology
• Molecular Biology
• Cancer Diagnostics

Background:

• GATA3 is a key transcription factor in epithelial cell differentiation.
• GATA3 immunostaining serves as a diagnostic marker for breast and urothelial cancers.
• GATA3 expression is also observed in various other neoplasms.

Purpose of the Study:

• To comprehensively evaluate GATA3 expression across a wide spectrum of normal and tumor tissues.
• To determine the diagnostic utility and prognostic significance of GATA3 in different cancer types.

Main Methods:

• Utilized a large-scale tissue microarray with 16,557 tumor samples (131 types) and 608 normal tissue samples (76 types).
• Performed immunohistochemistry to assess GATA3 protein expression levels.
• Correlated GATA3 expression with clinicopathological features and patient survival in breast cancer.

Main Results:

• GATA3 positivity was detected in 69 distinct tumor types.
• Highest positivity rates were observed in noninvasive papillary urothelial carcinoma (92-99%) and lobular breast carcinoma (98%).
• In breast cancer, low GATA3 staining correlated with advanced stage, higher grade, HER2 overexpression, hormone receptor negativity, and reduced survival.

Conclusions:

• GATA3 expression is present in a diverse range of tumor entities, extending beyond its established roles in breast and urothelial cancers.
• Diminished GATA3 levels are indicative of cancer progression and predict a poorer prognosis in breast cancer patients.